Equities research analysts expect Zoetis Inc (NYSE:ZTS) to post $0.66 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for Zoetis’ earnings, with the lowest EPS estimate coming in at $0.65 and the highest estimate coming in at $0.69. Zoetis reported earnings per share of $0.47 during the same quarter last year, which would suggest a positive year over year growth rate of 40.4%. The business is scheduled to announce its next earnings report on Thursday, February 15th.
According to Zacks, analysts expect that Zoetis will report full year earnings of $2.37 per share for the current year, with EPS estimates ranging from $2.34 to $2.40. For the next year, analysts anticipate that the company will report earnings of $2.72 per share, with EPS estimates ranging from $2.69 to $2.79. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side analysts that follow Zoetis.
Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, November 2nd. The company reported $0.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.63 by $0.02. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.32 billion. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. The company’s revenue was up 8.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.52 EPS.
A number of equities research analysts have recently weighed in on ZTS shares. BMO Capital Markets set a $65.00 target price on shares of Zoetis and gave the company a “hold” rating in a research note on Wednesday, October 25th. BidaskClub raised shares of Zoetis from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 12th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $75.00 target price on shares of Zoetis in a research note on Tuesday, October 24th. Cowen set a $80.00 target price on shares of Zoetis and gave the company a “buy” rating in a research note on Friday, November 17th. Finally, Morgan Stanley raised shares of Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 target price on the stock in a research note on Wednesday, November 29th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $68.82.
Shares of Zoetis (NYSE ZTS) opened at $72.04 on Friday. The firm has a market cap of $35,440.00, a PE ratio of 37.92, a PEG ratio of 2.17 and a beta of 1.06. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80. Zoetis has a 52 week low of $52.00 and a 52 week high of $73.58.
The company also recently announced a quarterly dividend, which will be paid on Thursday, March 1st. Shareholders of record on Friday, January 19th will be issued a $0.126 dividend. The ex-dividend date is Thursday, January 18th. This is a boost from Zoetis’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a yield of 0.70%. Zoetis’s payout ratio is 22.11%.
Institutional investors have recently modified their holdings of the business. Northwestern Mutual Wealth Management Co. raised its holdings in Zoetis by 16.8% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,598 shares of the company’s stock worth $100,000 after buying an additional 230 shares during the last quarter. Steward Partners Investment Advisory LLC purchased a new position in Zoetis in the third quarter worth about $114,000. Harfst & Associates Inc. raised its holdings in Zoetis by 16.1% in the second quarter. Harfst & Associates Inc. now owns 1,878 shares of the company’s stock worth $117,000 after buying an additional 260 shares during the last quarter. Almanack Investment Partners LLC. purchased a new position in Zoetis in the second quarter worth about $119,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in Zoetis by 251.9% in the third quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock worth $121,000 after buying an additional 1,360 shares during the last quarter. 93.19% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: “Brokerages Anticipate Zoetis Inc (ZTS) Will Post Earnings of $0.66 Per Share” was posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.thelincolnianonline.com/2018/01/14/brokerages-anticipate-zoetis-inc-zts-will-post-earnings-of-0-66-per-share-updated-updated.html.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.